MetLife Investment Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Buy |
|
|||||
|
2025
Q1 | $246K | Buy |
|
|||||
|
2024
Q4 | $139K | Sell |
|
|||||
|
2024
Q3 | $222K | Hold |
|
|||||
|
2024
Q2 | $334K | Buy |
|
|||||
|
2024
Q1 | $519K | Hold |
|
|||||
|
2023
Q4 | $600K | Hold |
|
|||||
|
2023
Q3 | $570K | Hold |
|
|||||
|
2023
Q2 | $1.3M | Buy |
|
|||||
|
2023
Q1 | $1.14M | Hold |
|
|||||
|
2022
Q4 | $1.03M | Hold |
|
|||||
|
2022
Q3 | $1.06M | Hold |
|
|||||
|
2022
Q2 | $876K | Buy |
|
|||||
|
2022
Q1 | $34K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $10.7K | Buy |
|
|||||
|
2018
Q4 | $5.94K | Sell |
|
|||||
|
2018
Q3 | $8.9K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $2.98M | Buy |
|
|||||
|
2017
Q4 | $2.8M | Buy |
|